Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Retatrutide is an investigational drug under active development by Eli Lilly through the TRIUMPH Phase 3 clinical trial programs
Free international shipping on orders over $200
Other patients with absorption deficiencies like celiac or those with history of gastric bypass surgery should also discuss with their doctor if treatment with a GLP-1 is right for them
A hydrated body handles GLP-1 changes much better than a dehydrated one
Myo/D-Chiro Inositol
Retatrutide is part of a new class of obesity medications sometimes nicknamed triple agonists. While popular drugs like Ozempic target one hormone pathway, GLP-1, and Zepbound activates two GLP-1 and GIP retatrutide targets three hormone receptors at once: GLP-1, GIP, and glucagon
US$ 24.38
US$ 27.48
US$ 26.04
US$ 22.31
US$ 26.89
US$ 20.50
US$ 27.24
US$ 22.25
US$ 24.42
